834798-18-4 Usage
Uses
Used in Pharmaceutical Applications:
N2-[2-(Dimethylamino)ethyl]-2,3-pyridinediamine is used as a therapeutic agent for its potential to target specific cellular pathways, making it a valuable molecule for research and drug development in the medical field.
Used in Cancer Treatment:
In the field of oncology, N2-[2-(Dimethylamino)ethyl]-2,3-pyridinediamine is used as an anticancer agent. Its unique structure allows it to interact with cellular mechanisms in ways that can inhibit tumor growth and progression, offering a promising avenue for the treatment of various types of cancer.
Used in Drug Development:
N2-[2-(Dimethylamino)ethyl]-2,3-pyridinediamine's potential as a drug candidate is being explored for its ability to modulate biological processes relevant to disease conditions. Researchers are investigating its efficacy and safety in preclinical and clinical trials to advance its use in medicine.
Used in Research:
N2-[2-(Dimethylamino)ethyl]-2,3-pyridinediamine serves as a subject of study in biochemical and medicinal chemistry research. Scientists are examining its interactions with biological targets to understand its mechanisms of action and to optimize its therapeutic potential.
While the provided materials do not specify different industries for the uses of N2-[2-(Dimethylamino)ethyl]-2,3-pyridinediamine, the compound's applications are inherently linked to the pharmaceutical and medical research industries due to its potential as a therapeutic agent and a subject of scientific inquiry.
Check Digit Verification of cas no
The CAS Registry Mumber 834798-18-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,4,7,9 and 8 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 834798-18:
(8*8)+(7*3)+(6*4)+(5*7)+(4*9)+(3*8)+(2*1)+(1*8)=214
214 % 10 = 4
So 834798-18-4 is a valid CAS Registry Number.
834798-18-4Relevant academic research and scientific papers
Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
-
Page/Page column 7, (2008/06/13)
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
